Efficacy Study to Evaluate B-Lock™ as an Antimicrobial Lock Solution in Dialysis Patients With a CVC

NCT01989091 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

270

Enrollment

INDUSTRY

Sponsor class

Stopped Did not meet predetermined primary endpoint

Conditions

Dialysis Catheter Infections

Interventions

DEVICE: B-Lock
DRUG: Heparin 5,000 U/mL

Sponsor

Great Lakes Pharmaceuticals Inc.